Literature DB >> 14961591

No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.

Gesche Tallen1, Ines Kaiser, Sonja Krabbe, Ulrike Lass, Christian Hartmann, Günter Henze, Karl Riabowol, Andreas von Deimling.   

Abstract

The ING1 family of proteins has been shown to have regulatory functions in oncogenesis, apoptosis, DNA repair and cell cycle regulation. Here we present the first report on LOH analysis of the ING1 locus, mutation analysis of the complete coding sequence including intron-exon boundaries and expression analysis of the different ING1 splice products and protein isoforms in primary brain tumours. No somatic ING1 mutations were detected. Semi-quantitative analysis revealed higher levels of p33ING1b RNA in benign than in malignant lesions. This correlation was significant in a subset of 37 astrocytic tumours WHO grades I to IV. ING1 protein isoforms p47ING1a, p33ING1b and p24ING1c were found to be expressed variably in this series. Our findings support a regulatory contribution of ING1 to the development or progression of brain tumours. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961591     DOI: 10.1002/ijc.11715

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Authors:  Remy Pedeux; Sagar Sengupta; Jiang Cheng Shen; Oleg N Demidov; Shin'ichi Saito; Hitoshi Onogi; Kensuke Kumamoto; Stephen Wincovitch; Susan H Garfield; Mary McMenamin; Makoto Nagashima; Steven R Grossman; Ettore Appella; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  Adenovirus-mediated expression of p33(ING1b) induces apoptosis and inhibits proliferation in gastric adenocarcinoma cells in vitro.

Authors:  Yifei Lv; Bibek Kumar Purbey; Yanhua Huang; Shuang Li; Gurung Radha; Zhiming Hao
Journal:  Gastric Cancer       Date:  2012-01-12       Impact factor: 7.370

Review 3.  Inhibitor of growth tumor suppressors in cancer progression.

Authors:  Brad Piche; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

4.  Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.

Authors:  Ute Gesche Tallen; Matthias Truss; Frank Kunitz; Sven Wellmann; Brad Unryn; Brigitte Sinn; Ulrike Lass; Sonja Krabbe; Nikola Holtkamp; Christian Hagemeier; Reinhard Wurm; Guenter Henze; Karl T Riabowol; Andreas von Deimling
Journal:  J Neurooncol       Date:  2007-09-01       Impact factor: 4.130

Review 5.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

6.  ING1 induces apoptosis through direct effects at the mitochondria.

Authors:  P Bose; S Thakur; S Thalappilly; B Y Ahn; S Satpathy; X Feng; K Suzuki; S W Kim; K Riabowol
Journal:  Cell Death Dis       Date:  2013-09-05       Impact factor: 8.469

7.  p33ING1b methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.

Authors:  Chun-Gang He; Qin-Yuan Huang; Li-Sheng Chen; Zhi-An Ling; Hong-Gen Wu; Hong-Qiang Deng
Journal:  Oncol Lett       Date:  2014-02-28       Impact factor: 2.967

Review 8.  ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer.

Authors:  Anna Melekhova; Aria Baniahmad
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

9.  Expression of P33(ING1b) Protein in Colorectal Cancer.

Authors:  Somayeh Fallahnezhad; Mehdi Nikbakht; Saeed Shokri
Journal:  Middle East J Dig Dis       Date:  2016-01

10.  mRNA and protein of p33ING1 in normal and cancer tissues.

Authors:  Shuang Zhao; Hua-Chuan Zheng
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.